Showing results (651-660 of 1,006) with videos related to
Sort By:
Pageof 101
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1982
In vitro metabolic activation of the pulmonary toxin, 4-ipomeanol, in nonciliated bronchiolar epithelial (Clara) and alveolar type II cells isolated from rabbit lungT R Devereux, K G Jones, J R Bend, et al.Journal of Natural Products|November 1, 1994
Novel naphthoquinones from Conospermum incurvumJ R Dai, L A Decosterd, K R Gustafson, et al.The Journal of Organic Chemistry|April 24, 2004
Gymnangiamide, a cytotoxic pentapeptide from the marine hydroid Gymnangium regaeDennis J Milanowski, Kirk R Gustafson, Mohammad A Rashid, et al.Journal of Molecular Biology|January 8, 1999
Solution structure by NMR of circulin A: a macrocyclic knotted peptide having anti-HIV activityN L Daly, A Koltay, K R Gustafson, et al.The Journal of Organic Chemistry|November 7, 2019
Chemoenzymatic Synthesis of (-)-Ribisins A and B from Dibenzo[b,d]furanDerek R Boyd, Narain D Sharma, Christopher J McGivern, et al.Translational Oncology|July 29, 2022
Micro-hydrogel injectables that deliver effective CAR-T immunotherapy against 3D solid tumor spheroidsAnisha B Suraiya, Vera J Evtimov, Vinh X Truong, et al.The Journal of Antimicrobial Chemotherapy|October 1, 1986
Improvement of the bioavailability of the anti-herpes virus agent BVDU by use of 5'-O-alkoxycarbonyl derivatives with increased metabolic stabilityM R Boyd, M Cole, M R Harnden, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1988
Flavone-8-acetic acid augments systemic natural killer cell activity and synergizes with IL-2 for treatment of murine renal cancerR H Wiltrout, M R Boyd, T C Back, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 26, 1998
Dopamine D4 receptors and the risk of cigarette smoking in African-Americans and CaucasiansP G Shields, C Lerman, J Audrain, et al.Antimicrobial Agents and Chemotherapy|May 1, 1993
Specific inhibition of the reverse transcriptase of human immunodeficiency virus type 1 and the chimeric enzymes of human immunodeficiency virus type 1 and type 2 by nonnucleoside inhibitorsA Hizi, R Tal, M Shaharabany, et al.Pageof 101